SAB Biotherapeutics (SABS) Amortizatization of Intangibles: 2021-2025

Historic Amortizatization of Intangibles for SAB Biotherapeutics (SABS) over the last 5 years, with Sep 2025 value amounting to $22,000.

  • SAB Biotherapeutics' Amortizatization of Intangibles changed negligibly% to $22,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $85,344, marking a year-over-year decrease of 45.91%. This contributed to the annual value of $237,093 for FY2024, which is 137.09% up from last year.
  • SAB Biotherapeutics' Amortizatization of Intangibles amounted to $22,000 in Q3 2025, which was down 0.00% from $22,000 recorded in Q2 2025.
  • In the past 5 years, SAB Biotherapeutics' Amortizatization of Intangibles ranged from a high of $83,994 in Q1 2024 and a low of $19,344 during Q4 2024.
  • Over the past 3 years, SAB Biotherapeutics' median Amortizatization of Intangibles value was $22,000 (recorded in 2025), while the average stood at $28,465.
  • In the last 5 years, SAB Biotherapeutics' Amortizatization of Intangibles spiked by 235.98% in 2024 and then crashed by 73.81% in 2025.
  • SAB Biotherapeutics' Amortizatization of Intangibles (Quarterly) stood at $41,206 in 2021, then plummeted by 40.02% to $24,716 in 2022, then climbed by 20.48% to $29,779 in 2023, then slumped by 35.04% to $19,344 in 2024, then remained steady at $22,000 in 2025.
  • Its Amortizatization of Intangibles was $22,000 in Q3 2025, compared to $22,000 in Q2 2025 and $22,000 in Q1 2025.